CIK 0001232524 · Large accelerated filer
Jazz Pharmaceuticals plc
Sign in to watch- Ticker
- JAZZ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- operating
- EIN
- 981032470
- Phone
- 353-1-634-7800
- Business address
- FIFTH FLOOR, WATERLOO EXCHANGE, WATERLOO ROAD, DUBLIN, Ireland, D04 E5W7
- Former names
- JAZZ PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,420,682
- in 10 filings, $24.9M under 10b5-1 plans
Net −$41,420,682. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- COZADD BRUCE C −$20.4M Director sold 20% of stake
- Iannone Robert −$19.2M EVP, Global Head of R&D & CMO sold 54% of stake
- GALA RENEE D −$1.2M President & CEO sold 3% of stake
- Carr Patricia −$327K SVP, Chief Accounting Officer sold 18% of stake
- Patil Neena M −$289K EVP & Chief Legal Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-16 | Henderson Mary Elizabeth SVP, Technical Operations | Grant or award | +10,116 | 29,624 | ||
| 2026-01-16 | Pearce Samantha EVP, Chief Commercial Officer | Grant or award | +3,637 | 44,592 | ||
| 2026-01-16 | Pearce Samantha EVP, Chief Commercial Officer | Shares withheld for taxes | −1,599 | $171.16 | $274K | 42,993 |
| 2026-01-16 | Carr Patricia SVP, Chief Accounting Officer | Grant or award | +2,370 | 9,382 | ||
| 2026-01-16 | Patil Neena M EVP & Chief Legal Officer | Grant or award | +8,852 | 56,614 | ||
| 2026-01-16 | Patil Neena M EVP & Chief Legal Officer | Returned to the company | −3,275 | $171.16 | $561K | 53,339 |
| 2026-01-16 | Iannone Robert EVP, Global Head of R&D & CMO | Grant or award | +11,699 | 84,398 | ||
| 2026-01-16 | Iannone Robert EVP, Global Head of R&D & CMO | Shares withheld for taxes | −4,140 | $171.16 | $709K | 80,258 |
| 2026-01-16 | GALA RENEE D President & CEO | Grant or award | +12,741 | 120,601 | ||
| 2026-01-16 | GALA RENEE D President & CEO | Shares withheld for taxes | −5,371 | $171.16 | $919K | 115,230 |
| 2026-01-16 | COZADD BRUCE C Director | Grant or award | +35,917 | 429,249 | ||
| 2026-01-16 | COZADD BRUCE C Director | Shares withheld for taxes | −17,453 | $171.16 | $3.0M | 411,796 |
| 2025-12-09 | Henderson Mary Elizabeth SVP, Technical Operations | Sale | −2,238 | $169.51 | $379K | 19,508 |
| 2025-12-05 | Carr Patricia SVP, Chief Accounting Officer | Sale | −160 | $171.11 | $27K | 7,012 |
| 2025-12-05 | Carr Patricia SVP, Chief Accounting Officer | Option exercise | +4,500 | $140.67 | $633K | 11,512 |
| 2025-12-05 | Carr Patricia SVP, Chief Accounting Officer | Sale | −4,500 | $171.20 | $770K | 7,012 |
| 2025-12-05 | Carr Patricia SVP, Chief Accounting Officer | Option exercise · Non-Qualified Stock Option (right to buy) | −4,500 | 0 | ||
| 2025-12-05 | GALA RENEE D President & CEO | Shares withheld for taxes | −80 | $166.91 | $13K | 107,860 |
| 2025-12-02 | O'Keefe Kenneth W Director | Shares withheld for taxes | −603 | $173.07 | $104K | 25,811 |
| 2025-11-26 | COZADD BRUCE C Director | Option exercise | +76,689 | $123.36 | $9.5M | 470,021 |
Page 8 of 19 · 365 trades